Skip to main content
Clinical Trials/DRKS00000329
DRKS00000329Not yet recruitingNot Applicable

Optimization of the medical diagnostics and therapy managing in colorectal tumors using F-18-Deoxyglucose (FDG) positron emission tomography (PET) and gene expression data (GenPET Colon-2008). - GenPET Colon

Deutsches Krebsforschungszentrum0 sites80 target enrollmentStarted: February 19, 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • Patients with a histologically confirmed primary colorectal carcinoma

Exclusion Criteria

  • rejection of the examination by the patient
  • diabetes mellitus
  • acute psychosis and other diseases with limited possibilities to understand the examination
  • pregnant women
  • claustrophobic patients

Investigators

Sponsor
Deutsches Krebsforschungszentrum

Similar Trials